About RetinalGeniX
RetinalGeniX is a company based in United States founded in 2014. RetinalGeniX has raised $698.09 thousand across 2 funding rounds. RetinalGeniX has completed 1 acquisition, including DNA/GPS. RetinalGeniX offers products and services including Pharmaco-Genetic Mapping, RetinalGeniX DNA/RNA GPS, and High-Resolution Retinal Monitoring. RetinalGeniX operates in a competitive market with competitors including Optomed, EarlySight, LKC Technologies, Eyenuk and Wooptix, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Retinalgenix Technologies Inc.
-
Annual Revenue
Not available
-
Net Profit
-$4.32 M (USD)-106.65as on Dec 31, 2024
-
EBITDA
-$4.32 M (USD)-106.81as on Dec 31, 2024
-
Total Equity Funding
$698.09 K (USD)
in 2 rounds
-
Latest Funding Round
$653.09 K (USD), Series A
Jan 23, 2024
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RetinalGeniX
RetinalGeniX offers a comprehensive portfolio of products and services, including Pharmaco-Genetic Mapping, RetinalGeniX DNA/RNA GPS, and High-Resolution Retinal Monitoring.
Screens and profiles genetic data for systemic and retinal disorders.
Monitors and creates markers for ocular and neurodegenerative diseases.
Provides 24/7 real-time alerts for patients and physicians.
Funding Insights of RetinalGeniX
RetinalGeniX has successfully raised a total of $698.09K across 2 strategic funding rounds. The most recent funding activity was a Series A round of $653.09 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by RetinalGeniX
RetinalGeniX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DNA/GPS.
Investment portfolio details for RetinalGeniX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of a genomic-based system for diagnoses of systemic diseases
|
Locked | Locked | 0 | Locked |
Complete acquisition details for RetinalGeniX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - RetinalGeniX
Detailed financials for RetinalGeniX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Retinalgenix Comparisons
Peer comparison for RetinalGeniX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RetinalGeniX
RetinalGeniX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Optomed, EarlySight, LKC Technologies, Eyenuk and Wooptix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of handheld fundus cameras and software solutions for eye screening
|
|
| Locked | Locked | Locked |
Retinal imaging solutions for detecting disorders are provided.
|
|
| Locked | Locked | Locked |
Non-mydriatic hand-held devices for visual electrophysiology testing are developed.
|
|
| Locked | Locked | Locked |
AI-driven retinal image analysis for diabetic retinopathy detection is developed.
|
|
| Locked | Locked | Locked |
Application that allows 3D capture using single standard camera
|
|
| Locked | Locked | Locked |
Ocular diagnostic for chronic diseases
|
Detailed competitors of RetinalGeniX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Retinalgenix
Complete news archive for RetinalGeniX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RetinalGeniX
RetinalGeniX was founded in 2014 and raised its 1st funding round 7 years after it was founded.
RetinalGeniX is headquartered in United States.
RetinalGeniX is a funded company, having raised a total of $698.09K across 2 funding rounds to date.
RetinalGeniX was established in 2014 in the United States. Focus is placed on the development and production of medical devices within the healthcare sector, particularly for ophthalmology applications. Diagnostic tools for diabetic retinopathy are created to support clinical assessments. Operations are centered in the U.S., with the companys online presence maintained at retinalgenix.com. No additional services beyond device manufacturing are indicated.
RetinalGeniX's top competitors include Heidelberg Engineering, Eyenuk and Optomed.
RetinalGeniX offers Pharmaco-Genetic Mapping, RetinalGeniX DNA/RNA GPS, and High-Resolution Retinal Monitoring.
RetinalGeniX has made 1 acquisition, including DNA/GPS.